Showing results (211-220 of 269) with videos related to
Sort By:
Pageof 27
Anti-Cancer Drug Design|February 1, 1993
Growth inhibition of human tumor cell lines by antisense oligonucleotides designed to inhibit p120 expressionL Perlaky, Y Saijo, R K Busch, et al.Biochemistry|October 3, 1989
Biochemical and pharmacological properties of p170 and p180 forms of topoisomerase IIF H Drake, G A Hofmann, H F Bartus, et al.Cancer Research|April 1, 1987
Relationship between the intracellular effects of camptothecin and the inhibition of DNA topoisomerase I in cultured L1210 cellsM R Mattern, S M Mong, H F Bartus, et al.Proceedings of the National Academy of Sciences of the United States of America|June 1, 1984
Copper metallothionein of yeast, structure of the gene, and regulation of expressionT R Butt, E J Sternberg, J A Gorman, et al.Cancer Chemotherapy and Pharmacology|January 1, 1981
DNA breakage activity of the methanol extract of auromomycinD M Kalvin, C H Huang, M A Lischwe, et al.Biochemical Pharmacology|July 4, 2001
Hepatic distribution of a phosphorothioate oligodeoxynucleotide within rodents following intravenous administrationM J Graham, S T Crooke, K M Lemonidis, et al.Clinical Pharmacology and Therapeutics|December 1, 1994
A pharmacokinetic evaluation of 14C-labeled afovirsen sodium in patients with genital wartsS T Crooke, L R Grillone, A Tendolkar, et al.Anti-Cancer Drug Design|January 1, 1997
Toxicological properties of several novel oligonucleotide analogs in miceS P Henry, J E Zuckerman, J Rojko, et al.Molecular Pharmacology|December 1, 1986
Purification, characterization, and structural properties of a single protein from rat basophilic leukemia (RBL-1) cells possessing 5-lipoxygenase and leukotriene A4 synthetase activitiesG K Hogaboom, M Cook, J F Newton, et al.Biochemistry|November 19, 1985
Molecular structure of the beta-adrenergic receptorR G Shorr, D R McCaslin, M W Strohsacker, et al.Pageof 27